Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable publication which meets basic scientific principles

Data source

Reference
Reference Type:
publication
Title:
Effect of tetrachlorophthalic anhydride on hepatic microsomal metabolism in rats and mice.
Author:
Ridley WP, Warren J
Year:
1988
Bibliographic source:
J Toxicol Environ Health. 24: 217-227

Materials and methods

Objective of study:
other: hepatic microsomal metabolism
Principles of method if other than guideline:
The capacity for induction of microsomal metabolic enzymes by tetrachlorophthalic anhydride (TCPA) was evaluated in male Sprague-Dawley rats. The rats (6/dose group) were orally dosed for 7 days with the test substance suspended in corn oil at dose rates of 25, 100, 250, and 500 mg/kg bw. Phenobarbital was used as positive control, negative control animals were treated with vehicle or remained untreated. Paralysis time was monitored following i.p. injection of zoxazolamine (75-100 mg/kg bw) and hexobarbital (150-200 mg/kg bw). Concentration of microsomal cytochrome P-450, acitivities of aminopyrine N-demethylase and aniline hydroxylase were determined in liver homogenates.
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Tetrachlorophthalic anhydride
EC Number:
204-171-4
EC Name:
Tetrachlorophthalic anhydride
Cas Number:
117-08-8
Molecular formula:
C8Cl4O3
IUPAC Name:
tetrachloro-1,3-dihydro-2-benzofuran-1,3-dione
Details on test material:
- Name of test material (as cited in study report): Tetrachlorophthalic anhydride
- Analytical purity: 99.8%
- Impurities (identity and concentrations): 0.2% hexachlorobenzene

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories
- Weight at study initiation: 150-260 g
- Housing: single
- Diet (e.g. ad libitum): certified Purina Rat Chow pellets
- Water (e.g. ad libitum): tap water


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25±2
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: Tetrachlorophthalic anhydride (TCPA) dosing suspensions were prepared by grinding crystalline TCPA to a fine powder in a mortar, sifting it through a fine wire screen and adding the resulting material to corn oil with continuous stirring. Animals were dosed by oral intubation with TCPA at a dose volume of 4-5 ml/kg bw.
Duration and frequency of treatment / exposure:
single
Doses / concentrations
Remarks:
Doses / Concentrations:
25, 100, 250, and 500 mg/kg bw
No. of animals per sex per dose / concentration:
6
Control animals:
yes, concurrent vehicle
Positive control reference chemical:
Phenobarbital
Details on study design:
- Dose selection rationale: Dose levels for TCPA were selected based on the results of preliminary studies. In the rat, over the 7-d dosing period, mortality was observed at 5000 mg/kg bw (5 out of 8 animals died) and at 1500 mg/kg bw (3 out of 8 animals died). Therefore, 500 mg/kg bw was the highest dose level used in the rat. At both 500 and 250 mg/kg bw in the rat, weight gain was significantly lower in the treated groups when compared with the control. No difference in weight gain between treated and control rats was observed at 100 and 25 mg/kg bw.
Statistics:
Phenobarbital treatment groups were compared with the control by Student’s t-test, and multiple TCPA treatment groups were compared with the control by Dunnett's test.

Results and discussion

Any other information on results incl. tables

Following treatment, a dose-dependent reduction in the zoxazolamine paralysis time occurred over the dose range 100-500 mg/kg bw. At 100, 250 and 500 mg/kg bw of TCPA, the extent of paralysis was 75%, 66% and 44% of control, respectively. No significant difference in paralysis time between the control and treated groups was found at a TCPA dose level of 25 mg/kg bw for two experimental runs. No effect on the hexobarbital sleep time was observed at any test level.

Phenobarbital caused a significant increase in the microsomal protein levels and the liver to body weight ratio, while TCPA at dose levels of 25-500 mg/kg-d produced no change in these parameters.

TCPA was found to produce statistically significant increases in hepatic aminopyrine N-demethylase, aniline hydroxylase, and cytochrome P-450 in the rat at 500 mg/kg bw (Table 1). In addition statistically significant increases were seen in aniline hydroxylase and cytochrome P-450 at 25 mg/kg bw but not at 250 mg/kg bw.

Table 1. Effects of Phenobarbital and TCPA on the Activities of Liver Microsomal Enzymesa

Test substance

Dose level (mg/kg bw)b

Cytochrome

P-450c

Aminopyrine N-demethylased

Aniline hydroxylasee

Control

-

1.26 ± 0.09

1.94 ± 0.38

0.86 ± 0.15

Phenobarbital

80

2.22 ± 0.61f

5.18 ± 0.85f

1.50 ± 0.19f

Control

-

1.35 ± 0.11

2.04 ± 0.60

0.86 ± 0.09

TCPA

25

1.47 ± 0.21

2.05 ± 0.37

1.13 ± 0.10

TCPA

250

1.60 ± 0.22

2.32 ± 0.47

1.05 ± 0.20

Control

-

1.30 ± 0.06

3.77 ± 0.47

1.08 ± 0.12

TCPA

25

1.59 ± 0.16h

3.54 ± 0.40

1.42 ± 0.25h

TCPA

500

1.70 ± 0.24g

5.09 ± 1.14h

1.54 ± 0.23g

aValues expressed as mean ±SD.

bPhenobarbital was dosed ip for 4 d; TCPA was dosed orally for 7 d.

cIn nmol P-450/mg microsomal protein.

dIn nmol formaldehyde/min/mg microsomal protein.

eIn nmol p-aminophenol/min/mg microsomal protein.

fSignificantly different from the control, p < 0.01, by Student's t-test.

gSignificantly different from the control' p < 0.01, by Dunnett's test.

hSignificantly different from the control, p < 0.05, by Dunnett's test.

Applicant's summary and conclusion